Vendor, Bannockburn, IL, part of Novartis Corp.
Novartis Gene Therapies Inc.
UEI H1YRZN8TQBC3, CAGE 8BDQ4
1 award and $0 obligated between March 11, 2024 and June 8, 2026, 100% under full and open competition, against 999.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36F79720D0225March 11, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | Adm Update Signature AuthorityNAICS 325412, PSC 6505 | $0 |
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 12 across 1 awards